Related Experiment Video
Updated: Jan 9, 2026
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
Radix Aucklandiae inhibits M1 macrophage polarization to alleviate ulcerative colitis by modulating gut microbial
Wen-Yin Tang1, Jia-Xuan Zhang1, Yin-Xia Hu2
1Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China; Guangdong Basic Research Center of Excellence for Integrated Traditional and Western Medicine for Qingzhi Diseases, Guangzhou 510515, PR China.
Background:
Radix Aucklandiae (RA) is a traditional Chinese medicine used to treat ulcerative colitis (UC). However, the underlying mechanism remains unclear.
Purpose:
This research sought to elucidate the mechanism of action of RA in UC in terms of the regulation of gut microbiota and M1 macrophage polarization.
Study Design:
The effects of RA on UC were studied through in vivo experiments conducted on UC mice, complemented by in vitro studies using RAW264.7 cells.
Methods:
3 % dextran sulfate sodium was used to induce UC in mice and treated with RA. Histopathological examination and colonic mucosal inflammation were evaluated after treatment. Changes in M1 macrophages in the colonic tissues were determined using immunofluorescence staining. Gut microbiota in feces was detected using 16S rRNA sequencing analysis. A metabolomic assay was used to determine the levels of tryptophan metabolites in the feces. To evaluate the effect of indole-3-aldehyde (I3A), both UC mouse and RAW264.7 cell models were used. RT-PCR was used to quantify the mRNA levels of TNF-α, IL-6, IL-1β, and aryl hydrocarbon receptor (AHR). The binding between I3A and AHR was assessed using the surface plasmon resonance assay.
Results:
RA improved ulcerative injury, decreased inflammatory cytokines levels in colonic tissues, and reduced M1 macrophages levels in mice. RA also regulated the composition of gut microbiota and the levels of tryptophan metabolites. RA and its primary components costunolide and dehydrocostuslactone, upregulated Lactobacillus reuteri, thereby promoting the production of tryptophan metabolite I3A. RA-elevated L. reuteri and I3A significantly reduced M1 macrophage level and alleviated UC in mice. Moreover, I3A directly inhibited M1 macrophage polarization and reduced TNF-α, IL-6, and IL-1β levels. I3A could strongly bind to AHR, thereby activating its signaling pathways and reducing the inflammatory responses in M1 macrophages.
Conclusion:
RA can treat UC through inhibiting the pro-inflammatory responses of M1 macrophages by increasing intestinal L. reuteri-mediated production of I3A.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...